Baird served as a bookrunner on this offering
AboutTabula Rasa HealthCare, Inc. (“Tabula Rasa” ) (NASDAQ:TRHC) recently completed a follow-on offering , which includes 1,350,000 shares offered by Tabula Rasa and 2,100,000 shares offered by certain stockholders of Tabula Rasa named in the preliminary prospectus supplement (the “Selling Stockholders”), at a price of $27.50 per share generating gross proceeds of approximately $95 million. Tabula Rasa intends to use all of the net proceeds from the offering to repay outstanding indebtedness under its credit facility. Tabula Rasa will not receive any proceeds from shares of common stock to be sold by the Selling Stockholders.
Tabula Rasa HealthCare, Inc. is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs, and manage risk. Medication risk management is Tabula Rasa’s lead offering, and its cloud-based software applications provide solutions for a range of payors, providers and other healthcare organizations. Tabula Rasa is headquartered in Moorestown, New Jersey.
CONTACT US TO LEARN MORE
- December 2017
- Tabula Rasa HealthCare, Inc.
- Target Geography
- North America